Warning: Trying to access array offset on value of type bool in /home/skomedia/public_html/gatekeeper.ng/wp-content/plugins/td-cloud-library/state/single/tdb_state_single.php on line 285

Warning: Trying to access array offset on value of type bool in /home/skomedia/public_html/gatekeeper.ng/wp-content/plugins/td-cloud-library/state/single/tdb_state_single.php on line 285

Warning: Trying to access array offset on value of type bool in /home/skomedia/public_html/gatekeeper.ng/wp-content/plugins/td-cloud-library/state/single/tdb_state_single.php on line 285

Warning: Trying to access array offset on value of type bool in /home/skomedia/public_html/gatekeeper.ng/wp-content/plugins/td-cloud-library/state/single/tdb_state_single.php on line 285

Warning: Trying to access array offset on value of type bool in /home/skomedia/public_html/gatekeeper.ng/wp-content/plugins/td-cloud-library/state/single/tdb_state_single.php on line 285

COVID-19: WHO Approves Covovax Vaccine For Emergency Use

Date:

The World Health Organisation (WHO) has approved the Covovax vaccine for Emergency Use Listing (EUL), elevating to nine the number of immunisations approved to fight the Coronavirus (COVID-19) pandemic.

The vaccine is produced by the Serum Institute of India, under licence from Novavax, and will now be part of the COVAX facility portfolio, boosting efforts to vaccinate more people in lower-income countries.

Dr. Mariângela Simão, WHO Assistant Director-General for Access to Medicines and Health Products, said that “even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2.”

She said WHO hoped the new Indian-produced shots would increase access, particularly in lower-income countries, 41 of which have still not been able to vaccinate 10 per cent of their populations, while 98 countries have yet to reach 40 per cent.

According to WHO, the procedure to qualify for emergency use assesses the quality, safety and efficacy of the vaccines. The approval also allows countries to expedite their own regulatory process.

The Technical Advisory Group for Emergency Use Listing (TAG-EUL), convened by WHO and made up of experts from around the world, determined that the vaccine meets WHO standards for protection against COVID-19, that the benefits far outweighs any risks and that it can be used globally.

Covovax is a subunit of the vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI). It requires two doses and is stable at 2 to 8 °C refrigerated temperatures.

This week, a meeting of WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) also reviewed the vaccine.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

SAT Home Teachers Ld

spot_imgspot_img

Popular

More like this
Related

2023: Adamu, APC Govs Hold ‘Crucial’ Meeting

Adams Oshiomole, Deputy Director of APC Presidential Campaign Council and seven governors arrived for a crucial meeting with the National Chairman of the party, Senator Abdullahi Adamu.

Soludo Not Working Against Peter Obi’s Ambition

The allegations that Anambra State Governor, Professor Chukwuma Soludo is working against the ambition of the Labour Party presidential candidate, Peter Obi in 2023 elections are false.

BBNaija Season 7: MultiChoice Presents N100m Grand Prize To Winner

Big Brother Naija Level Up housemate, Phyna, was presented with a brand new Innoson SUV and N50 million cheque for emerging winner of Season 7 of the reality TV show.

Why LASG Is Building Biggest Mental Rehabilitation Home – Sanwo Olu

Lagos State Governor, Mr. Babajide Sanwo-Olu said the state government is currently building the biggest mental rehabilitation home in the country to comprehensively address the menace of drug abuse and provide the necessary care for victims.